EUVIMEDEUVIMED entdecken
Crossref

Crocetin inhibits choroidal neovascularization in both in vitro and in vivo models

Caixia Wang, Xuejing Li, Jing Su, Jialiang Duan, Yimin Yao, Qingli Shang

Experimental Eye Research · 2024

DOI: 10.1016/j.exer.2023.109751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2024. Verfasst von Caixia Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China. Hauptthemen laut MEDLINE: Endothelial Cells, Choroidal Neovascularization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Choroidal neovascularization (CNV) is the primary pathogenic process underlying wet age-related macular degeneration, leading to severe vision loss. Despite current anti-vascular endothelial growth factor (VEGF) therapies, several limitations persist. Crocetin, a major bioactive constituent of saffron, exhibits multiple pharmacological activities, yet its role and mechanism in CNV remain unclear. Here, we investigated the potential effects of crocetin on CNV using in vitro and in vivo models. In human umbilical vein endothelial cells, crocetin demonstrated inhibition of VEGF-induced cell proliferation, migration, and tube formation in vitro, as assessed by CCK-8 and EdU assays, transwell and scratch assays, and tube formation analysis. Additionally, crocetin suppressed choroidal sprouting in ex vivo experiments. In the human retinal pigment epithelium (RPE) cell line ARPE-19, crocetin attenuated cobalt chloride-induced hypoxic cell injury, as evidenced by CCK-8 assay. As evaluated by quantitative PCR and Western blot assay, it also reduced hypoxia-induced expression of VEGF and hypoxia-inducible factor 1α (HIF-1α), while enhancing zonula occludens-1 expression. In a laser-induced CNV mouse model, intravitreal administration of crocetin significantly reduced CNV size and suppressed elevated expressions of VEGF, HIF-1α, TNFα, IL-1β, and IL-6. Moreover, crocetin treatment attenuated the elevation of phospho-S6 in laser-induced CNV and hypoxia-induced RPE cells, suggesting its potential anti-angiogenic effects through antagonizing the mechanistic target of rapamycin complex 1 (mTORC1) signaling. Our findings indicate that crocetin may hold promise as an effective drug for the prevention and treatment of CNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsChoroidal NeovascularizationMiceAnimalsHumansVascular Endothelial Growth Factor ASincalideHypoxiaDisease Models, AnimalRetinal Pigment EpitheliumCarotenoidsVitamin A

Stichwörter der Autor:innen

Cell proliferationChoroidal neovascularizationCrocetinHypoxic injureVascular endothelial growth factormTORC1 signaling pathway

Substanzen

Vascular Endothelial Growth Factor ASincalidetrans-sodium crocetinateCarotenoidsVitamin A

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
  • Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China. Electronic address: qinglishang@hb2h.com.

Förderung

  • Natural Science Foundation of Hebei Province

Zitieren

APA

Wang, C., Li, X., Su, J., Duan, J., Yao, Y., & Shang, Q. (2024). Crocetin inhibits choroidal neovascularization in both in vitro and in vivo models. Experimental Eye Research. https://doi.org/10.1016/j.exer.2023.109751

Vancouver

Wang C, Li X, Su J, Duan J, Yao Y, Shang Q. Crocetin inhibits choroidal neovascularization in both in vitro and in vivo models. Experimental Eye Research. 2024. doi:10.1016/j.exer.2023.109751

BibTeX
@article{Wang2024,
  author = {Wang, Caixia and Li, Xuejing and Su, Jing and Duan, Jialiang and Yao, Yimin and Shang, Qingli},
  title = {Crocetin inhibits choroidal neovascularization in both in vitro and in vivo models},
  journal = {Experimental Eye Research},
  year = {2024},
  doi = {10.1016/j.exer.2023.109751}
}
Kostenlos starten →